Recruiting
Phase 3

Ustekinumab & Guselkumab

Sponsor:

Janssen Research & Development, LLC

Code:

NCT05083182

Conditions

Arthritis, Juvenile

Eligibility Criteria

Sex: All

Age: 5 - 17

Healthy Volunteers: Not accepted

Interventions

Ustekinumab

Guselkumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information